[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Jichao Qin\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":161},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,45,71,89,108,133],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100603661","the-clinical-significance-of-examining-metastatic-lymph-nodes-in-individual-gastric-mesenteries-in-the-patients-with-gastric-cancer-undergoing-gastrectomy-100603661",false,"NCT07139418","The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy","The Clinical Significance of Examining Metastatic Lymph Nodes in Respective Gastric Mesenteries in the Gastric Cancer Patients Who Received D2 Lymphadenectomy Plus Complete Mesogastric Excision","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years\n2. Primary gastric adenocarcinoma confirmed by preoperative pathology result\n3. cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition\n4. Patients who received gastrectomy with D2 lymphadenectomy plus complete mesogastric excision\n5. American Society of Anesthesiologists (ASA) class I, II, or III\n6. Written informed consent\n\nExclusion Criteria:\n\n1. Negative preoperative biopsy\n2. Too late tumour stage or metastasis (cT4b\u002FM1)\n3. BMI\\>30 kg\u002Fm2\n4. Total gastrectomy or proximal gastrectomy\n5. previous neoadjuvant chemotherapy or radiotherapy\n6. Previous upper abdominal surgery\n7. Combined with other malignant diseases\n8. Reject operation","ALL","18 Years","85 Years",{"count":20,"type":21},400,"ESTIMATED","1 Month","OBSERVATIONAL","This study aims to examine the predictive value of metastatic gastric mesenteries, which contains metastatic lymph node, in 6 gastric mesenteries; and importantly, to further evaluate the relationship between the number of metastatic gastric mesenteries and prognosis in the gastric cancer patients who received D2+complete mesogastric excision (CME).",[26],"Gastric Carcinoma",[28,29,30,31],"Gastric cancer","Complete mesogastric excision","Gastric mesentery","Lymph node metastasis","RECRUITING","2026-03-08",{"date":35,"type":36},"2026-03-11","ACTUAL",{"date":38,"type":36},"2025-10-07",{"date":40,"type":21},"2030-08-30",{"name":42,"class":43},"Jichao Qin","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":53,"targetDuration":55,"studyType":23,"phases":4,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":44},"100572100","analysis-of-lymph-node-metastasis-and-tumor-deposit-in-the-short-gastric-mesentery-following-total-gastrectomy-for-gastric-cancer-100572100","NCT06728878","Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer","Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy With D2 Lymphadenectomy Plus Complete Mesogastric Excision for Gastric Cancer: A Prospective Observational Study","zytg001","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years\n2. Primary gastric adenocarcinoma confirmed by preoperative pathology result\n3. cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition\n4. Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision\n5. American Society of Anesthesiologists (ASA) class I, II, or III\n6. Written informed consent\n\nExclusion Criteria:\n\n1. Negative preoperative biopsy\n2. Too late tumour stage or metastasis (cT4b\u002FM1)\n3. BMI\\>30 kg\u002Fm2\n4. previous neoadjuvant chemotherapy or radiotherapy\n5. Previous upper abdominal surgery\n6. Combined with other malignant diseases\n7. Reject operation",{"count":54,"type":21},150,"3 Years","This study aims to explore lymph node metastasis in the short gastric mesentery following total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision, providing evidence-based medicine for standardizing lymph node dissection in gastric cancer.",[58],"Gastric Cancers",[28,60,61,31,62],"Lymph node dissection","Short gastric mesentery","Tumor location","2025-08-25",{"date":65,"type":36},"2025-09-02",{"date":67,"type":36},"2024-05-01",{"date":69,"type":21},"2027-12-31",{"name":42,"class":43},{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":79,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":81,"conditions":82,"keywords":83,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":85,"startDateStruct":86,"completionDateStruct":87,"leadSponsor":88,"locationsCount":44},"100572713","exploration-of-lymph-node-metastasis-and-tumor-deposit-in-the-posterior-gastric-mesentery-for-distal-gastric-cancer-100572713","NCT06736847","Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer","Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery Following D2 Lymphadenectomy Plus Complete Mesogastric Excision in Patients Who Received Distal Gastrectomy: A Prospective Observational Study","zydgc001","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years\n2. Primary gastric adenocarcinoma confirmed by preoperative pathology result\n3. cT2-4N0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 7th Edition\n4. Patients who received distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision\n5. American Society of Anesthesiologists (ASA) class I, II, or III\n6. Written informed consent\n\nExclusion Criteria:\n\n1. Negative preoperative biopsy\n2. Too late tumour stage or metastasis (cT4b\u002FM1)\n3. BMI\\>30 kg\u002Fm2\n4. Total gastrectomy or proximal gastrectomy\n5. previous neoadjuvant chemotherapy or radiotherapy\n6. Previous upper abdominal surgery\n7. Combined with other malignant diseases\n8. Reject operation",{"count":80,"type":21},200,"This study aims to evaluate lymph node metastasis and tumor deposit in the posterior gastric mesentery following distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (CME) in gastric cancer.",[26],[28,60,84,31],"Posterior gastric mesentery",{"date":65,"type":36},{"date":67,"type":36},{"date":69,"type":21},{"name":42,"class":43},{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":97,"targetDuration":55,"studyType":23,"phases":4,"briefSummary":99,"conditions":100,"keywords":101,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":104,"startDateStruct":105,"completionDateStruct":106,"leadSponsor":107,"locationsCount":44},"100572101","analysis-of-tumor-deposit-at-the-fusion-site-of-the-right-gastric-mesentery-and-left-gastric-mesentery-in-the-patients-with-gastric-cancer-who-received-proximal-gastrectomy-100572101","NCT06728891","Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy","Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy With D2 Lymphadenectomy Plus Complete Mesogastric Excision for Gastric Cancer: A Prospective Observational Study","zypg001","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years\n2. Primary gastric adenocarcinoma confirmed by preoperative pathology result\n3. cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition\n4. Patients undergoing proximal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision\n5. American Society of Anesthesiologists (ASA) class I, II, or III\n6. Written informed consent\n\nExclusion Criteria:\n\n1. Negative preoperative biopsy\n2. Too late tumour stage or metastasis (cT4b\u002FM1)\n3. BMI\\>30 kg\u002Fm2\n4. previous neoadjuvant chemotherapy or radiotherapy\n5. Previous upper abdominal surgery\n6. Combined with other malignant diseases\n7. Reject operation",{"count":98,"type":21},100,"This study aims to evaluate the tumor deposit at the fusion site of the right gastric mesentery and left gastric mesentery in the patients with gastric cancer who received proximal gastrectomy.",[26],[28,60,102,103],"Right gastric mesentery","Tumor deposit",{"date":65,"type":36},{"date":67,"type":36},{"date":69,"type":21},{"name":42,"class":43},{"id":109,"slug":110,"hasResults":11,"nctId":111,"briefTitle":112,"officialTitle":113,"acronym":4,"eligibilityCriteria":114,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":115,"enrollmentInfo":116,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":118,"conditions":119,"keywords":121,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":44},"100437746","mesogastrium-metastasis-in-colon-cancer-100437746","NCT04980287","Mesogastrium Metastasis in Colon Cancer","Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure","Inclusion Criteria:\n\n* Age between 18 and 75 years\n* American Society of Anesthesiologists (ASA) score I to III\n* A biopsy proven histological diagnosis of colorectal carcinoma\n* Preoperative staging cT2-4aN0M0 or cTanyN+M0\n* tumor located at hepatic flexure or transverse colon close to flexures\n* Undergoing complete mesocolic excision with right gastric mesentery resection\n* Patients have to be aware of the aim of the trial, and have signed the informed consent.\n\nExclusion Criteria:\n\n* Synchronous colorectal carcinoma\n* Clinical evidence of metastasis\n* History of colorectal cancer or other malignant tumors\n* Preoperative staging cT1N0 or cT4bNany\n* Emergency procedure","75 Years",{"count":117,"type":21},50,"Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.",[120],"Colon Cancer",[122,123,124],"colon adenocarcinoma","metastasis","right hemi-colectomy","2025-04-07",{"date":127,"type":36},"2025-04-10",{"date":129,"type":36},"2021-01-12",{"date":131,"type":21},"2026-07-19",{"name":42,"class":43},{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":4,"eligibilityCriteria":139,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":140,"targetDuration":4,"studyType":142,"phases":143,"briefSummary":145,"conditions":146,"keywords":148,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":44},"100439185","artificial-intelligence-assists-surgeons-decision-making-100439185","NCT04999007","Artificial Intelligence Assists Surgeons' Decision Making","Artificial Intelligence-assisted Decision Making for Temporary Ileostomy: A Prospective Randomized Controlled Trail.","Inclusion Criteria:\n\n1. Aged older than 18 years and younger than 85 years.\n2. Primary rectal adenocarcinoma confirmed by preoperative pathology result.\n3. Expected curative resection via total mesorectal excision procedure.\n4. American Society of Anesthesiologists (ASA) class I, II, or III.\n5. Written informed consent.\n\nExclusion Criteria:\n\n1. Pregnant or breastfeeding women.\n2. Severe mental disorder or language communication disorder.\n3. Hartmann surgery or colostomy is performed intraoperatively.\n4. Interrupted of surgery for more than 30 minutes due to any cause.\n5. Malignant tumors with other organs",{"count":141,"type":21},616,"INTERVENTIONAL",[144],"NA","This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.",[147],"Rectal Cancer",[149,150,151,152],"artificial intelligence,","rectal cancer","temporary ileostomy","anastomotic leakage","2024-11-18",{"date":155,"type":36},"2024-11-21",{"date":157,"type":36},"2021-09-02",{"date":159,"type":21},"2025-10",{"name":42,"class":43},""]